ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,356.02
0.03%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cullinan Therapeutics Inc (CGEM) Share Price

CGEM Cullinan Therapeutics Inc

22.40
-0.14 (-0.62%)
07 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Cullinan Therapeutics Inc NASDAQ:CGEM NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.14 -0.62 22.40 20.00 24.52 22.78 22.05 22.41 270,925 21:51:37   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics  -153.16M -3.5565 -6.31 966.39M
 Type  Size  Price  Time  Units 
 9 2 21.34 22:36:02 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore CGEM News
05/06/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
04/06/202422:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/06/202413:12EDGAR2Form 8-K - Current report
01/06/202412:00GLOBECullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
24/05/202413:00GLOBECullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Summit
23/05/202422:07EDGAR2Form 8-K - Current report
23/05/202422:04GLOBECullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024
Period
Draw mode
Data Downloads for CGEM

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Cullinan Therapeutics Inc Articles